Whalegun
Home

Neurocrine Biosciences NBIX paid Capitol Counsel $60K for lobbying in Q1 2026 · Budget, Health Issues and 1 more issue

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q1 2026
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
26/04/16

Up 0.0% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Neurocrine Biosciences's other lobbying reports

Neurocrine Biosciences NBIX paid Capitol Counsel $60K for lobbying in Q1 2026 · Budget, Health Issues and 1 more issue | Whalegun